Market Signal Briefing

KT-621 BROADEN2 Phase 2b trial in AD ongoing, with data expected by mid-2027

KT-621 BREADTH Phase 2b trial in asthma initiated, with data expected in late-2027

KT-579 Phase 1 HV clinical trial expected to start in 1Q26, with data expected in 2H26

Advancing at least one new development candidate towards IND for a first-in-class, oral immunology program in 2026

Well-capitalized with $1.6 billion1 in cash and runway into 2029

Kymera to present its 2026 objectives at the J.P. Morgan 44th Annual Healthcare Conference today at 9:00 a.m. PT/12:00 p.m. ET

WATERTOWN, Mass., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced its anticipated 2026 preclinical and clinical milestones across its industry leading oral immunology pipeline.

“Kymera enters 2026 from a position of exceptional strength, driven by significant progress in the clinic and the consistent execution of our strategy,” said Nello Mainolfi, PhD, Founder, President and CEO, Kymera Therapeutics. “Across our programs, we delivered upon and, in many cases, exceeded expectations in 2025, best exemplified by the first-in-industry STAT6 data in healthy volunteers and AD patients with our novel oral degrader, KT-621. We have built a powerful engine for innovation, paired with the scientific expertise and strong execution required to translate novel ideas into first-in-class medicines that address the limitations of today’s immunology treatments. Our growing portfolio of oral programs reflects our ability to develop medicines with the potential to combine biologics-like efficacy and safety profiles with the improved convenience and patient access of oral drugs.”

Dr. Mainolfi continued, “With multiple clinical readouts ahead, an early pipeline of undisclosed first-in-class programs, and an exceptionally strong cash balance, we have the foundation to shape the future of immunology. By reimagining how many common immuno-inflammatory diseases are treated, we aim to expand the reach of advanced therapies and deliver oral medicines that fundamentally can change the standard of care for patients.”

Additional details on Kymera's pipeline and progress will be presented today at the J.P. Morgan Healthcare Conference.

STAT6 Degrader Program
KT-621 is an investigational, first-in-class, once daily, oral degrader of STAT6, the specific transcription factor responsible for IL-4/IL-13 signaling and the central driver of Type 2 inflammation, and currently in Phase 2 clinical testing. KT-621, the first STAT6-directed drug to enter clinical evaluation, has the potential to transform treatment paradigms for more than 140 million patients around the world, including children and adults, suffering from Type 2 diseases such as atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD), eosinophilic esophagitis (EoE), chronic rhinosinusitis with nasal polyps (CRSwNP), chronic spontaneous urticaria (CSU), prurigo nodularis (PN), and bullous pemphigoid (BP), among others.

Recent KT-621 Updates

In December 2025, the Company reported positive results from the KT-621 BroADen Phase 1b clinical trial in moderate to severe AD patients. After 28 days of daily dosing, KT-621 demonstrated deep STAT6 degradation in blood and skin, robust reductions in disease-relevant Type 2 inflammatory biomarkers in blood, skin and lungs, and meaningful improvements in clinical endpoints and patient-reported outcomes on signs and symptoms in atopic dermatitis as well as comorbid asthma and allergic rhinitis, with a favorable safety and tolerability profile. The impact on biomarkers and clinical endpoints was in line or numerically exceeded data reported from dupilumab studies after 4 weeks of treatment. FDA Fast Track designation was granted to KT-621 in December 2025 for the treatment of moderate to severe AD.Dosing commenced in November 2025 for the KT-621 BROADEN2 Phase 2b trial, a global, randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and tolerability of three doses of KT-621 in approximately 200 patients with moderate to severe AD over 16 weeks. BROADEN2 was recently expanded to include adolescents (ages 12-18) in addition to adults. The primary endpoint is the percent change from baseline in Eczema Area and Severity Index (EASI) score at week 16. Secondary endpoints will evaluate a range of additional safety, efficacy, and quality of life measures.In January 2026, the Company initiated the BREADTH Phase 2b clinical trial, a global, randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and tolerability of three doses of KT-621 in approximately 264 adult patients with moderate to severe eosinophilic asthma over 12 weeks. The primary endpoint is the percent change from baseline in pre-bronchodilator of forced expiratory volume in one second (FEV1). Secondary endpoints will evaluate a range of additional safety, efficacy, and quality of life measures. Key Upcoming KT-621 Milestones:

Complete enrollment of the BROADEN2 Phase 2b AD trial in 2026, with data expected to be reported by mid-2027. Commence dosing in the BREADTH Phase 2b asthma trial in the first quarter of 2026, with data expected to be reported in late-2027. IRF5 Degrader Program
KT-579 is an investigational, first-in-class, oral degrader of IRF5, a genetically validated transcription factor and master regulator of immunity. KT-579 has the potential to selectively block inflammation and restore immune regulation by inhibiting pro-inflammatory cytokines, Type I IFN, and autoantibody production while sparing normal cell function. KT-579 has the potential to be the first novel mechanism with broad utility in diseases where effective and well tolerated oral therapies are needed, such as lupus, Sjögren's, inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), among others.

Recent KT-579 Updates

The Company has completed IND-enabling studies for the program. In preclinical studies, KT-579 degraded IRF5 across multiple preclinical species and in all disease-relevant tissues. In preclinical models of lupus and RA, KT-579 was equal or more efficacious than small molecule inhibitors and biologics currently marketed or in the clinic. In preclinical safety studies, KT-579 did not show any adverse effects of any type at all doses and concentrations tested. Key Upcoming KT-579 Milestones:

Initiate the first-in-human Phase 1 healthy volunteer trial in the first quarter of 2026, with data expected to be reported in the second half of 2026. Partnered Programs

KT-485/SAR447971, a selective, potent, oral IRAK4 degrader, is being advanced in collaboration with Sanofi for immuno-inflammatory diseases, with a Phase 1 clinical trial expected to initiate in 2026.Preclinical activities are ongoing under an exclusive option and license agreement with Gilead Sciences to advance the Company's oral CDK2 molecular glue program for the potential treatment of breast cancer and other solid tumors. Upon exercise of Gilead’s option, which would result in an option exercise payment to Kymera, Gilead would assume all responsibility to develop, manufacture and commercialize all products resulting from the collaboration. Research
Leveraging its unique target selection strategy, proven small molecule discovery capabilities, and deep development expertise, Kymera is building an industry leading portfolio of innovative oral immunology medicines addressing high value undrugged targets for areas of significant patient need.

Key Upcoming Milestones:

The Company intends to advance at least one new development candidate towards IND for a first-in-class, oral immunology program in 2026. J.P. Morgan Healthcare Conference
Kymera will present its 2026 objectives at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 9:00 a.m. PT (12:00 p.m. ET). A live webcast of the presentation and Q&A session will be available under “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. A replay of the webcast and the presentation will be archived on Kymera’s website following the event.

1Unaudited, estimated cash as of December 31, 2025.

About Kymera Therapeutics
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X or LinkedIn.

Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, implied and express statements about our expectations regarding strategy, business plans and objectives on the development of our clinical and preclinical pipeline, including the therapeutic potential, clinical benefits and safety thereof, including for the Phase 1b data readout of KT-621 in AD patients in December 2025, the initiation of Phase 2b studies of KT-621 in patients with AD and asthma in the fourth quarter of 2025 and first quarter of 2026, respectively, the effect of initial parallel development of Phase 2b studies in AD and asthma patients on acceleration of late parallel development across multiple indications, and the preliminary cross-study assessments comparing non-head-to-head clinical data of KT-621 to published data for dupilumab, the advancement of KT-579 into Phase 1 clinical testing in early 2026, the KT-485/SAR447971 program, objectives on the development of CDK2 degraders, and Kymera’s financial condition and expected cash runway into 2029. The words "may," "might," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "expect," "estimate," "seek," "predict," "future," "project," "potential," "continue," "target," “upcoming” and similar words or expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from any forward-looking statements contained in this press release, including, without limitation, risks associated with: the risk that cross-trial comparisons may not be reliable as no head-to-head trials have been conducted comparing KT-621 to dupilumab, and Phase 1 clinical data for KT-621 may not be directly comparable to dupilumab’s clinical data due to differences in molecule composition, trial protocols, dosing regimens, and patient populations and characteristics, that preclinical and clinical data, including the results from the Phase 1 trials of KT-621, are not predictive of, may be inconsistent with, or more favorable than, data generated from future or ongoing clinical trials of the same product candidate, uncertainties inherent in the initiation, timing and design of future clinical trials, the availability and timing of data from ongoing and future clinical trials and the results of such trials, the ability to successfully demonstrate the safety and efficacy of drug candidates, the timing and outcome of planned interactions with and submissions to regulatory authorities, the availability of funding sufficient for our operating expenses and capital expenditure requirements, the ability of each party to perform its obligations under the Kymera and Gilead exclusive option and license agreement, the unexpected emergence of adverse events or other undesirable side effects during preclinical and clinical development, whether Kymera will be able to fund development activities and achieve development goals, including those under the Kymera and Gilead collaboration, and other factors. These risks and uncertainties are described in greater detail in the section entitled "Risk Factors" in the most recent Quarterly Report on Form 10-Q and in subsequent filings with the SEC. In addition, any forward-looking statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent date. We explicitly disclaim any obligation to update any forward-looking statements. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements.

Investor and Media Contact: 

Justine Koenigsberg
Vice President, Investor Relations
[email protected]
[email protected]
857-285-5300 

HomeStock IdeasLong IdeasIndustrial 

SummaryRobert Half trades at an 80% discount from its 2022 peak, despite operating cash flows declining only 40%.I see early 2026 as a likely inflection point, with macro headwinds fading and tailwinds—including lower rates and reshoring—gaining strength.RHI’s consulting arm (Protiviti) remains resilient, offsetting cyclical weakness in core staffing; international consulting grew 9.6% in 2025 YTD.My DCF-based fair value is $49/share, implying 70% upside, with risks from litigation, capital allocation, and macro conditions. design master/iStock via Getty Images

Introduction Since the Federal Reserve started hiking interest rates in 2022, the staffing industry has been absolutely brutalized. Robert Half’s stock (RHI) is down from a peak of $121 per share in February 2022

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Latest smartwatch for mariners offers satellite and cellular connectivity for added peace of mind, enhanced boat mode and more

, /PRNewswire/ -- Garmin (NYSE: GRMN) today announced quatix® 8 Pro, the ultimate nautical smartwatch equipped with inReach® technology for two-way satellite and cellular connectivity1 – giving mariners access to text messaging, voice calling, SOS capabilities and more without a cell phone connection. Packed with essential marine features to control the vessel, the watch's enhanced boat mode brings boating apps to the forefront when mariners are out on the water, then hides those features while they're ashore. Available in a 47mm case, quatix 8 Pro includes a bright 1.4" AMOLED display, a durable titanium bezel, scratch resistant sapphire lens and superior battery life, making it the ultimate companion on and off the water.

The ultimate nautical smartwatch equipped with built-in satellite and cellular connectivity gives mariners access to text messaging, voice calling, SOS capabilities and more from the wrist. "From fishing to fitness, wakesurfing to weight lifting, quatix 8 Pro helps keep mariners connected through every part of their day, even when bringing a smartphone along isn't practical or possible. With satellite and LTE connectivity on the wrist, mariners can feel more at ease knowing they can stay in touch with family and friends or get help if needed. And with the upgraded boat mode, it's easier for them to access the features they need, when they need them."
–Susan Lyman, Garmin Vice President of Consumer Sales and Marketing

Stay connected without a phone

With built-in inReach technology1, quatix 8 Pro helps mariners stay in touch and have greater peace of mind when their voyages take them off the grid, even up to 50 miles offshore. Using a satellite connection, they can send messages and location check-ins, while staying on top of changing weather forecasts – no phone connection required. Cellular connectivity gives mariners access to voice calling, voice messaging and LiveTrack location sharing. And with SOS capabilities, they can trigger an SOS message to get help from the 24/7-staffed Garmin Response℠ coordination center, with experience coordinating more than 1,200 inReach incidents on the water.

Quickly take command

The enhanced boat mode feature makes it easier than ever for mariners to control the helm while on the water and navigate to the activities they want while on land. When activated, boat mode brings vital vessel-connected apps to the forefront, providing quick access to autopilot, trolling motor and other boating data – right from the watch face. When boat mode is deactivated and it's time to head to the office, the gym or anywhere in between, users can get the apps and everyday connected features they want back in focus in their menus and watch face.

Packed with premium features

Designed for life on and off the water, quatix 8 Pro boasts a suite of dedicated marine features, including chartplotter voice commands2 and remote control over entertainment and lighting systems, Force® trolling motors and more, along with 24/7 health and wellness monitoring, more than 100 activities like wakesurfing and water skiing, navigation features, Garmin Pay™ and much more.

Available to purchase on www.garmin.com starting January 16, 2026, quatix 8 Pro has a suggested retail price of $1,299.99 and gets up to 15 days of battery life in smartwatch mode. To learn more, visit garmin.com.

Engineered on the inside for life on the outside, Garmin products have revolutionized life for anglers, sailors, mariners and boat enthusiasts everywhere. Committed to developing the most innovative, highest quality, and easiest to use marine electronics the industry has ever known, Garmin believes every day is an opportunity to innovate and a chance to beat yesterday. For the 11th consecutive year, Garmin was named the Manufacturer of the Year by the National Marine Electronics Association (NMEA). Visit the Garmin Newsroom, email our media team, connect with @garminmarine on social, or follow our blog.

1 Active subscription required; LTE network coverage and satellite connectivity are not available in all countries, e.g., satellite coverage up to 50 miles offshore. Check garmin.com/quatix8procoverage for requirements and to see which services are accessible in your area – or in countries to where you may be traveling. Some jurisdictions regulate or prohibit satellite communication devices; it is the user's responsibility to know and follow all applicable laws.
2 Requires Bluetooth connectivity

About Garmin International, Inc. Garmin International, Inc. is a subsidiary of Garmin Ltd. (NYSE: GRMN). Garmin Ltd. is incorporated in Switzerland, and its principal subsidiaries are located in the United States, Taiwan and the United Kingdom. Garmin, quatix, inReach, Fusion and Force are registered trademarks and Garmin Messenger and Garmin Pay are trademarks and Garmin Response is a service mark of Garmin Ltd. or its subsidiaries. All other brands, product names, company names, trademarks and service marks are the properties of their respective owners. All rights reserved.

Notice on Forward-Looking Statements:
This release includes forward-looking statements regarding Garmin Ltd. and its business. Such statements are based on management's current expectations. The forward-looking events and circumstances discussed in this release may not occur and actual results could differ materially as a result of known and unknown risk factors and uncertainties affecting Garmin, including, but not limited to, the risk factors listed in the Annual Report on Form 10-K for the year ended December 28, 2024, filed by Garmin with the Securities and Exchange Commission (Commission file number 0-31983), and the Quarterly Report on Form 10-Q for the quarter ended September 26, 2025 filed by Garmin with the Securities and Exchange Commission (Commission file number 001-41118). Copies of such Form 10-K and Form 10-Q are available at https://www.garmin.com/en-US/investors/sec/. No forward-looking statement can be guaranteed. Forward-looking statements speak only as of the date on which they are made and Garmin undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

MEDIA CONTACTS:
Brianna Silverman and Carly Hysell
913-397-8200
[email protected]

SOURCE Garmin International, Inc.

January 13, 2026 07:01 ET  | Source: Rathbones Group PLC

8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)   Full name of discloser:Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
        Use a separate form for each offeror/offereeThe Unite Group Plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e)   Date position held/dealing undertaken:
        For an opening position disclosure, state the latest practicable date prior to the disclosure12/01/2026(f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
        If it is a cash offer or possible cash offer, state “N/A”Yes 2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:25p Ord InterestsShort positions Number%Number%(1)   Relevant securities owned and/or controlled:593,9350.12%  (2)   Cash-settled derivatives:    (3)   Stock-settled derivatives (including options) and agreements to purchase/sell:            TOTAL:

593,9350.12%   All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)      Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages:  3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit25p Ordinary SharesSale1,000569.45p (b)        Cash-settled derivative transactions

Class of relevant securityProduct description
e.g. CFDNature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit      (c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType
e.g. American, European etc.Expiry dateOption money paid/ received per unit         (ii)        Exercise

Class of relevant securityProduct description
e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit      (d)        Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing
e.g. subscription, conversionDetailsPrice per unit (if applicable)     4.        OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”None (b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i)   the voting rights of any relevant securities under any option; or
(ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”None (c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached?No Date of disclosure:13/01/2026Contact name:Hannah Rimmer – Compliance Department Telephone number:0151 243 7103 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at.

Global carrier orders 787-10 airplanes for international expansion Ultra-efficient, spacious widebody jets will also support fleet modernization Latest purchase brings Delta's order book to 130 Boeing airplanes as it builds future fleet , /PRNewswire/ -- Boeing (NYSE: BA) and Delta Air Lines today announced the U.S. carrier placed its first direct order for up to 60 787 Dreamliners to support long-haul international growth and renew the airline's widebody fleet. Delta's purchase of 30 787-10 jets – with opportunity for up to 30 more of the largest 787 variant – will enable the airline's expansion and modernization plans on high-demand transatlantic and South American routes.

Delta Air Lines orders up to 60 Boeing 787 Dreamliners to grow and modernize widebody fleet. "Delta is building the fleet for the future, enhancing the customer experience, driving operational improvements and providing steady replacements for less efficient, older aircraft in the decade to come," said Ed Bastian, Delta's chief executive officer. "Most importantly, these aircraft will be operated by the best aviation professionals in the industry, providing Delta's welcoming, elevated and caring service to travelers worldwide."

With capacity for up to 336 passengers and 25% lower fuel use than the airplanes it replaces, the 787-10 offers the lowest operating cost per seat of any widebody airplane. Delivering superior comfort for passengers, the 787 Dreamliner features the largest windows of any widebody airplane flying today and air that is pressurized at a lower cabin altitude, which will help Delta's customers arrive at their destinations feeling more refreshed.

"We are excited that Delta Air Lines has selected the 787-10 to join its fleet of the future. The 787 Dreamliner's unmatched efficiency, range, and passenger comfort make it a perfect fit for Delta's international expansion and fleet modernization," said Stephanie Pope, president and CEO of Boeing Commercial Airplanes. "Our team looks forward to delivering new Dreamliners to Delta and supporting their commitments to provide an exceptional passenger experience and advance sustainability in aviation."

With more than 460 Boeing airplanes currently in service, Delta has flown most Boeing single-aisle and widebody models across its domestic and international networks over the decades. This new widebody order further strengthens that partnership and supports U.S. aerospace manufacturing jobs across Boeing's production system and supply chain.

Today's purchase brings Delta's firm order book to 130 Boeing airplanes, including the airline's order for 100 737-10 jets. The efficiency and flexibility of the 787-10 and 737-10 will enable Delta to fly more passengers on more routes as the airline expands and diversifies its network.

A leading global aerospace company and top U.S. exporter, Boeing develops, manufactures and services commercial airplanes, defense products and space systems for customers in more than 150 countries. Our U.S. and global workforce and supplier base drive innovation, economic opportunity, sustainability and community impact. Boeing is committed to fostering a culture based on our core values of safety, quality and integrity.  

Contact
Boeing Media Relations
[email protected]

SOURCE Boeing

TROY, Mich., Jan. 13, 2026 /PRNewswire/ -- Adtalem Global Education Inc.'s recent report has investors wondering if the company's stock is fairly valued.

January 13, 2026 07:05 ET  | Source: Treace Medical Concepts, Inc.

PONTE VEDRA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced its preliminary, unaudited fourth quarter and full-year 2025 revenue results.

Highlights:

Preliminary revenue of $62.1 million to $62.5 million in the fourth quarter of 2025, an approximate 9% decrease at the midpoint over the same period in 2024.Preliminary revenue of $212.3 million to $212.7 million for the full-year 2025, an approximate 2% increase at the midpoint compared to the prior year and in-line with the previously provided revenue guidance range of $211 million to $213 million.New active surgeon additions of approximately 202 for full-year 2025; ended the year with approximately 3,337 active surgeons, a 6% increase compared to the prior year and approximately 33% of the estimated 10,000 U.S. surgeons performing bunion surgery. “Despite top-line headwinds, we are encouraged by our fourth-quarter progress. Surgeon adoption of our expanded suite of 3D bunion technologies again drove mid–single-digit case volume growth in the quarter,” said John T. Treace, CEO and Chairman of Treace. “Supported by our dedicated, bunion-focused sales force, these technologies position us to further penetrate the bunion market and expand our surgeon customer base. We maintain a leading position in the bunion market and remain focused on expanding our share of the bunion procedure market, improving profitability, and delivering long-term value to shareholders.”

2026 Outlook:
Treace is not issuing full-year 2026 guidance at this time, however, the Company anticipates continued positive procedure volume growth as well as the impact of previously disclosed dynamics, including headwinds related to broader economic conditions and softer consumer sentiment, as well as a product mix shift.

The Company plans to provide 2026 financial guidance during its fourth quarter 2025 earnings conference call, which is currently scheduled for Thursday, February 26, 2026, at 4:30 p.m. Eastern Time.

The preliminary unaudited financial information in this press release has not been subject to the more rigorous standards of review for Treace’s filed financial statements, may be adjusted, including as a result of its internal closing processes and the external auditing procedures of its independent registered public accounting firm, and remains subject to change until the Company files its full financial statements for 2025.

Treace to Present at J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026

John T. Treace, Chief Executive Officer, Chairman and Founder of Treace, will present at the J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, beginning at 7:30 am Pacific Time / 10:30 am Eastern Time. Following this presentation, Mr. Treace will be joined by Mark L. Hair, Chief Financial Officer of Treace, for a question-and-answer session. A live webcast and replay of the presentation will be available on the Company’s investor relations website at https://investors.treace.com/.

Forward-Looking Statements
This press release and statements made during the Company’s presentation and question-and-answer session at the J.P. Morgan Healthcare Conference contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements, including, but not limited to, anticipated fourth quarter and full-year 2025 revenue; expected increase in product adoptions and procedure volumes; expected improvements in profitability and liquidity; anticipated 2026 dynamics and headwinds; ability to effectively respond to and mitigate the impact of challenges in the current market environment, including in response to increased competition, evolving surgeon and patient preferences for minimally invasive bunion solutions, changes in tariff and trade policies, economic uncertainty or soft consumer sentiment; anticipated future product launches and the timing of such product launches; ability to increase case volumes, expand surgeon customer base and utilization rate, and increase procedure penetration and market share; expected seasonality; and anticipated pace of growth in the foot and ankle market. Forward-looking statements are based on management’s current assumptions and expectations of future events and trends, which affect or may affect the Company’s business, strategy, operations or financial performance, and actual results and other events may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Factors that could cause actual results or other events to differ materially from those contemplated in this press release can be found in the Risk Factors section of Treace’s public filings with the Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K for the year ended December 31, 2024, which was filed with the SEC on February 27, 2025 and any subsequent Quarterly Reports on Form 10-Q or Current Reports on Form 8-K. Because forward-looking statements are inherently subject to risks and uncertainties, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements speak only as of their date, and, except to the extent required by law, the Company undertakes no obligation to update these statements, whether as a result of any new information, future developments or otherwise. The Company’s preliminary, unaudited results for the fourth quarter and full year ended December 31, 2025, reflect the Company’s current estimates based on information available as of the date of this press release and are subject to change, including as a result of the completion of the Company’s financial and operating closing procedures, customary audit procedures, and other developments that may occur before the completion of these procedures. Accordingly, you should not place undue reliance on these preliminary, unaudited results, which may differ materially from actual results and are not necessarily indicative of its operating results for any future periods.

Internet Posting of Information
Treace routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.treace.com. The Company encourages investors and potential investors to consult the Treace website regularly for important information about Treace.

About Treace Medical Concepts
Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion and related midfoot deformities. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 67 million Americans, of which Treace estimates 1.1 million are annual surgical candidates. Treace has pioneered and patented the Lapiplasty®3D Bunion Correction® System – a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. To further support the needs of surgeons and bunion patients, Treace offers its Adductoplasty® Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, two systems for minimally invasive osteotomy procedures, namely the Nanoplasty® 3D Minimally Invasive Bunion Correction System and the Percuplasty™ Percutaneous 3D Bunion Correction System, and the SpeedMTP® MTP Fusion System. Treace continues to expand its footprint in the marketplace by extending its SpeedPlate® rapid compression implant platform to new applications, as well as providing surgeons with advanced digital solutions with its IntelliGuide™ patient specific, pre-op planning and cut guide technology. For more information, please visit www.treace.com.

To learn more about Treace, connect with us on LinkedIn, X, Facebook and Instagram.

Contacts:
Treace Medical Concepts
Mark L. Hair
Chief Financial Officer
[email protected]
(904) 373-5940

Investors:
Gilmartin Group
Philip Trip Taylor
[email protected]

Jamie Dimon says economy remains resilient and doesn't appear to be worsening

Many investors were focused on the Consumer Electronics Show (CES) in Las Vegas last week. However, one tech giant made news of its own at NRF 2026, the retail industry’s annual conference in New York.

Microsoft Today

$477.18 -2.10 (-0.44%)

As of 01/12/2026 04:00 PM Eastern

52-Week Range$344.79▼

$555.45Dividend Yield0.76%

P/E Ratio33.94

Price Target$630.37

Specifically, Microsoft Corp. NASDAQ: MSFT announced the rollout of Copilot Checkout. This is one way that Microsoft is using artificial intelligence (AI) to push into agentic commerce. With Copilot Checkout, users can complete purchases directly within its AI chatbot. This allows the retailer to remain the merchant of record, handling fulfillment and customer service.

Microsoft already sits at the center of how large retailers run supply chains, manage customer data, and integrate third-party software. The company believes its embedded position, which allows Microsoft to offer AI tools, data platforms, and automation capabilities, will give it an edge over other rivals such as OpenAI, Alphabet Inc. NASDAQ: GOOGL and Amazon.com Inc. NASDAQ: AMZN by enhancing a retailer’s existing operations without asking them to hand over customer relationships or transaction data.

Get Microsoft alerts:

The 2 Sides of the Copilot Checkout Debate It remains to be seen how quickly consumers will adopt chat-based commerce. Some critics argue that solutions like Copilot Checkout are akin to a new hammer looking for a nail, suggesting that e-commerce is not a problem that needs to be fixed.

However, Kathleen Mitford, corporate vice president of global industry marketing, makes the argument that consumer behavior is shifting faster than the market may be giving it credit for. Support for her argument comes from the rapid adoption of AI by businesses in the past year.

If Milford is correct, Microsoft is positioned as the “trusted operating system” for enterprise commerce. It provides the AI layer, cloud infrastructure via Azure, and productivity that works behind the scenes, while allowing merchants to retain ownership of their data.

The belief is that retailers want technology that can partner with them without becoming a competitor. That’s the lane that Microsoft is targeting as it tries to increase the Copilot market share, which is just a fraction of ChatGPT.

Analysts Remain Bullish on Microsoft Overall MarketRank™100th Percentile

Analyst RatingModerate Buy

Upside/Downside32.1% Upside

Short Interest LevelHealthy

Dividend StrengthStrong

News Sentiment1.05 Insider TradingSelling Shares

Proj. Earnings Growth12.39%

See Full Analysis

A feature like Copilot Checkout may not be enough to drive MSFT stock higher.

However, on Jan. 12, Goldman Sachs initiated coverage on the company with a Buy rating and a $655 price target.

In doing so, the firm refuted concerns about AI spending as a near-term drag with an uncertain payoff.

Instead, it cited the company’s positioning in the AI stack.

Specifically, Goldman Sachs remarked that Microsoft is the best placed among large-cap technology stocks to benefit from “compounding AI product cycles.”

Is MSFT Stock a Buy? MSFT stock is starting out 2026 in the same way it exited 2025. It’s down about 1.05% with about two weeks to go before earnings. The stock has been in a broad sell-off, which has pushed it down over 6% since the company last reported earnings at the end of October 2025.

However, the MSFT stock chart does have an attractive setup. For starters, it shows what looks to be a constructive consolidation phase. The stock has repeatedly tested and held a price near the 200-day simple moving average (SMA). That suggests this is a level that institutions are willing to defend.

Additionally, the price has stabilized, resulting in less volatility, and the MACD has begun to stabilize near the zero line. All of this is consistent with traders digesting prior gains rather than a breakdown from the existing trend.

By the way, MSFT stock remains in a bullish, long-term uptrend. That could change if the stock makes a deep contraction below the 200-day SMA on heavy volume. But for now, the argument still appears to be on the side of the bulls.

The company’s earnings report, which is scheduled for Jan. 28, could be the next strong catalyst for MSFT stock. For now, patience and a scaled approach may be better than aggressive buying.

Should You Invest $1,000 in Microsoft Right Now?Before you consider Microsoft, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Microsoft wasn't on the list.

While Microsoft currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Iran's currency, the rial, has collapsed to around 1 million per US dollar, a record that spotlights how quickly savings can be wiped out when trust in money breaks.

The currency lost nearly half its value across 2025, with official inflation reaching 42.5% in December. Recent protests erupting in Tehran's Grand Bazaar, triggered by the sharp fall in the rial and the volatility that makes it impossible for merchants to price inventory or plan purchases.

The state responded with a nationwide communications blackout, and some Iranians turned to Starlink to skirt the restrictions, even though using the satellite service is banned and criminalized in Iran.

Prior to the almost total collapse on Jan. 9, the rial had fallen to around 42,000 per USD. It then shot up to just under 1 million per USD and has remained around that level since. This is a loss of around 95% of its purchasing power overnight.

However, due to volatility within the country and the lack of utility, the reality is even worse, with quotes ranging from around 1 million to 1.5 million per USD.

Iran rial to dollar (Source: xe.com)The crisis is economic and political, but it's also infrastructural. When a government can shut down internet access to suppress protests, the question of whether Bitcoin functions as a safe haven depends not only on its design but on whether people can reach the network at all.

That dual challenge, consisting of currency debasement plus access denial, is the scenario Bitcoin's architecture was meant to address, even if the reality in 2026 is messier than the whitepaper imagined.

What Bitcoin was actually created to doThe Bitcoin whitepaper, published in 2008, frames the system as “a purely peer-to-peer version of electronic cash,” enabling online payments to be sent “directly from one party to another without going through a financial institution.”

That design goal was technical, eliminating the need for a trusted third party to validate transactions, but the choice to pursue it was political. The genesis block, mined in January 2009, embeds a message: “The Times 03/Jan/2009 Chancellor on brink of second bailout for banks.”

The Times' January 3, 2009 front page featured “Chancellor on brink of second bailout for banks,” the headline embedded in Bitcoin's genesis block.The reference is to the UK government preparing a second rescue of the banking system during the financial crisis, and it's widely interpreted as commentary on monetary fragility and the risks of relying on institutions that socialize losses while privatizing gains.

Bitcoin wasn't invented for Iran specifically, but it was invented for a world where trust in financial intermediaries can fail, and where a person might need to transfer value without permission from a bank, a government, or a payment processor.

The rial collapse makes that use case concrete.

What the rial collapse revealsThe rial's weakness is a symptom of structural dysfunction that makes daily economic life unworkable. The core issue for bazaar merchants is price volatility, not just depreciation.

When currency moves unpredictably, merchants can't decide whether to buy or sell inventory, and households can't plan purchases or save in local currency without watching their purchasing power evaporate.

Sanctions and institutional capture deepen the dysfunction. Sanctions combined with the Revolutionary Guards' economic dominance limit the state's ability to stabilize the economy, fueling a legitimacy crisis.

The World Bank expects Iran's economy to contract in 2026 amid high inflation and currency pressure, a baseline outlook that suggests the current crisis is more than a temporary shock.

That breakdown creates demand for alternatives, such as US dollars, gold, stablecoins, and Bitcoin, but it also triggers state countermeasures. Iran's Central Bank High Council has imposed caps of $5,000 on annual stablecoin purchases and $10,000 on holdings, a clear effort to curb digital dollarization and preserve the rial's role as the only legal tender.

The caps show that when people try to escape monetary debasement, governments treat that escape as a threat and move to close the exits.

The Iranian rial weakened from 892,000 per dollar in February 2025 to 1.5 million in January 2026, accelerating sharply after the December protests.Bitcoin as a hedge versus Bitcoin as a lifelineThe “Bitcoin is a safe haven” framing conflates two distinct claims.

The first is Bitcoin as a hedge, a store of value that preserves purchasing power when fiat currencies weaken. The second is Bitcoin as a lifeline, a payment rail that functions when banks and payment processors are unavailable or compromised.

Bitcoin as a hedge has clear advantages: limited supply, self-custody, portability, and protocol-level censorship resistance.

However, it also has clear drawbacks.

Price volatility means Bitcoin can lose 20% or 30% of its value in a matter of weeks, making it a poor substitute for stable purchasing power in the short term (but still better than losing 95% in hours.) On- and off-ramps are constrained, especially in jurisdictions with capital controls or aggressive enforcement.

Regimes can target exchanges, ban peer-to-peer trading, or impose severe penalties for non-compliance.

Bitcoin as a lifeline is a different proposition. Cross-border transfers without banks become possible, and the network can theoretically function with satellite or mesh connectivity when the traditional internet is blocked.

Yet, if the government shuts down fiat on-ramps and off-ramps, usage shifts to over-the-counter markets where prices diverge, liquidity thins, and user safety becomes non-trivial.

Gold shows the largest 52-week drawdown at approximately 70%, while Bitcoin and the dollar index exhibit moderate volatility compared to stablecoins' stability.Reuters reported that Starlink usage during Iran's blackout makes this concrete: access to the network matters as much as the protocol's design.

In many high-inflation environments, stablecoins become the first dollar substitute because they're less volatile than Bitcoin and easier to use for daily transactions. Yet Iran has moved to cap stablecoin purchases and holdings precisely because they undermine the state's monetary control.

That regulatory response illustrates the tension between what Bitcoin-style systems were built to enable and what governments will tolerate when those systems threaten the currency monopoly.

Three scenarios for what happens nextIran's trajectory will test whether censorship-resistant value transfer works in practice or gets contained by state power. Three scenarios capture the range of outcomes.

Crisis deepens, controls tighten. Prolonged unrest, harsher sanctions, more frequent blackouts, and tighter foreign exchange and crypto controls define this path.

The rial rate weakens further as confidence erodes, and crypto demand rises, but usage becomes more over-the-counter and informal. Starlink-style connectivity becomes a financial variable.

Watch for blackout frequency, enforcement actions against exchanges, and new restrictions on stablecoins or foreign exchange access.

Repression stabilizes the street but not the currency. A crackdown on protests fails to address structural inflation or institutional dysfunction.

The rial may stabilize temporarily at weak levels, but households still seek any non-rial store of value because trust in the currency remains broken. Watch for inflation prints, import restrictions, and the spread between official and parallel exchange rates.

Political reset or sanctions thaw. Leadership transition, negotiated sanctions relief, or trade normalization restores foreign exchange access and rebuilds some confidence in the currency.

The rial stabilizes or strengthens, and crypto demand shifts from necessity to speculation as households regain access to formal banking channels. Watch for signals of sanctions, oil export constraints, and reopenings of banking channels.

ScenarioTriggersWhat happens to IRRWhat happens to crypto usageBiggest risk to civiliansDeepening crisis / controls tightenProlonged unrest; harsher sanctions; more frequent internet blackouts; tighter FX/crypto restrictions; aggressive enforcementParallel IRR weakens further; official/parallel gap widens; volatility stays highDemand rises but shifts more OTC/informal; higher spreads/premiums; reliance on alternative connectivity growsAccess + safety: loss of connectivity/rails, higher legal exposure, scams/robbery risk in OTC marketsRepression / no macro fixCrackdowns stabilize streets but inflation persists; continued sanctions pressure; tighter import/price controlsTemporary stabilization at weak levels, punctuated by spikes; purchasing power still erodesMore “store-of-value” behavior (USD/gold/stablecoins/BTC) but with constrained on/off-ramps; slower, cautious adoptionSlow grind: falling real wages/savings, shortages, selective enforcement that punishes ordinary usersThaw / resetNegotiated sanctions relief; trade normalization; leadership/policy shift; improved FX access and banking channelsIRR stabilizes or strengthens; volatility declines; parallel premium compressesUsage shifts from necessity → speculation/portfolio; more activity on formal rails; OTC premiums fallWhiplash + unequal access: abrupt rule changes, winners/losers from re-opening, potential backlash against recent “exit” strategiesWhat Bitcoin was built to fix, and what it can'tIran's rial crisis isn't an outlier; it's part of a global pattern in which monetary instability drives safe-haven behavior. Gold reached record levels amid geopolitical and institutional uncertainty, while Bitcoin ticked up during periods of uncertainty in 2025.

That convergence shows people running to similar assets in different crises, reinforcing the thesis that demand for censorship-resistant value transfer rises as trust in institutions falls. However, the dual-use reality complicates the narrative.

When civilians use crypto defensively, states and sanctioned entities also experiment with crypto rails to evade restrictions and move value outside traditional financial systems.

That dynamic is why regulators remain aggressive even when humanitarian use cases are legitimate, as the same tools that help individuals escape currency controls can help regimes evade sanctions.

The rial collapse at 1 million per dollar is a reminder that money can stop working, and not in a theoretical sense, but in the practical sense that savings evaporate, merchants can't price goods, and the state uses inflation and capital controls to preserve power at the expense of purchasing power.

Bitcoin's architecture was designed for exactly that scenario: a system where value transfer doesn't require permission from a financial institution or a government, and where the supply is fixed rather than subject to political discretion.

But the reality in 2026 is that states fight back. Iran's stablecoin caps, internet blackouts, and enforcement actions show that governments treat alternative currencies as threats and move to close the exits when people try to escape monetary debasement.

The question isn't whether Bitcoin's design is censorship-resistant, as it is, but whether that resistance holds when governments can block internet access, target exchanges, criminalize usage, and impose severe penalties for non-compliance.

The answer depends on the infrastructure. If people can access the network through alternative connectivity like VPNs or satellite internet, and if peer-to-peer markets can function despite state opposition, then Bitcoin works as intended.

If access rails are shut down and enforcement makes use risky, the protocol's design doesn't matter because people can't reach it.

That's the test Iran's crisis poses: whether the system built to fix broken money can survive the backlash from states that depend on monetary control to maintain power.

Charles Hoskinson, founder of Cardano, has expressed concerns regarding the progress of crypto legislation in the United States. On January 12, 2026, Hoskinson suggested that failure to pass a comprehensive crypto bill in the first quarter of the year should result in the removal of the current crypto czar. This statement underscores growing apprehensions among industry leaders about regulatory developments.

Hoskinson’s comments come amid increasing pressure on lawmakers to provide a clear regulatory framework for the cryptocurrency industry. The absence of definitive guidelines is seen as a barrier to innovation and growth, potentially impacting the United States’ competitive position in the global digital asset market. According to Hoskinson, decisive action is needed to ensure the sector’s advancement.

U.S. regulators have historically focused on issues such as market integrity, investor protection, and surveillance-sharing when considering crypto legislation. These regulatory goals aim to ensure the safe and ethical operation of digital asset markets. However, the pace of regulatory development has been a point of contention within the industry, with many stakeholders calling for more rapid progress.

The cryptocurrency market, particularly Bitcoin, represents a significant portion of the digital asset landscape. Bitcoin is the largest cryptocurrency by market value, often serving as a benchmark for the broader market. The lack of comprehensive legislation affects various aspects of this ecosystem, including investor access and market stability.

Many institutional investors, including banks and asset managers, are eager to offer cryptocurrency products to meet growing client demand. The introduction of crypto-related financial products allows these institutions to tap into new revenue streams. However, regulatory uncertainty poses challenges for product development and deployment, creating potential operational risks.

Exchange-Traded Funds (ETFs) are among the financial products that issuers are keen to introduce in the cryptocurrency space. ETFs provide a way for investors to gain exposure to digital assets without directly buying them. The approval process for these products typically involves demonstrating adequate custody measures, ensuring market integrity, and protecting investors.

The competitive landscape for crypto ETFs is dynamic, with multiple issuers often filing for similar products. Amendments to filings are common as issuers seek to address regulatory concerns. The timeline for approval can be unpredictable, making it difficult for institutions to plan launches.

As the first quarter of the year progresses, stakeholders in the cryptocurrency industry will closely watch the development of legislative frameworks. The review periods, potential amendments, and requests for public comment will be critical components of the regulatory process. Industry players hope that swift and effective action will be taken to address these regulatory challenges.

Moving forward, the focus will be on how lawmakers respond to the industry’s calls for clear guidelines. The outcome of these discussions will significantly impact future developments in the cryptocurrency market. Until then, the industry remains in a state of anticipation, awaiting further regulatory clarity.

Post Views: 1

The Bitcoin price is continuing to push higher as a circumspect market looks on. Could this really be the start of the big rally that takes Bitcoin back to the highs, or will the bottoming process drag on further?

$BTC poised to break higher

Source: TradingView

The 4-hour chart for $BTC reveals that the price is poised at the brink of a breakout. After a fakeout on Monday, where the price went back inside the bull flag and all the way back to retest the $90,500 horizontal support, a bounce took place from there, and now the price has broken out again, retested, and looks ready to either break out or reject from the $92,000 horizontal resistance.

All looks good in the indicators at the bottom of the chart. The Stochastic RSI indicators are heading to the top, signalling upside price momentum, while the Relative Strength Index is showing the indicator line peeping above the downward trendline.

Bitcoin breaks out against gold

Source: TradingView

Zooming into the very low hourly time frame for the Bitcoin/gold ratio, it can be seen that $BTC has just edged through a downtrend against gold. Of course this is a very low time frame so caution is required, but in the high weekly time frame 19 ounces is the major support bottom for $BTC against gold. 25 ounces is the next big resistance level. Watch for Bitcoin to start redressing the balance against gold from now onward.

Bitcoin ready to move higher against all major assets

Source: TradingView

Moving out into the daily time frame for $BTC it can be observed that the price does appear to be breaking up through the $92,000 level. A move up to the key $94,000 horizontal resistance level now looks likely. 

A breakout of the ascending triangle (in green) would move a lot of eyes back to Bitcoin - eyes that have been focussed far more on the AI sector, as well as on gold and silver. These assets rapidly moved skywards as Bitcoin went in the opposite direction and foundered at a bottom for several weeks.

It’s now time for Bitcoin to rise against all these assets and especially against the US dollar. The next move is likely to take many by surprise.

Huge upside price momentum inbound?

Source: TradingView

So what can be said for the bears as we zoom right out into the high time frame? Probably the only real concern is that a bear flag is still in play. That said, the ascending triangle fits the price action a lot better, and if this pattern holds firm, the measured move up to the key $108,000 horizontal resistance level would nullify the bear flag anyway. 

The market is generally unaware that Bitcoin could be about to tear higher. Sentiment is deep in the Fear segment, and the vast majority of  retail investors have moved to the AI and precious metals sectors in the belief that these are going to continue posting higher gains. They may well do so, but the $BTC price is at the bottom for just about all of these assets when their ratios are compared. Mean reversion is about to take place.

Finally, one only has to look at the Stochastic RSI indicators for the weekly, 2-weekly, and monthly time frames. All are at their respective bottoms. The weekly is the first to rise, and as can be seen, the indicator lines are just about to both pass through the 20.00 level. Huge upside price momentum is inbound.

Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

Patching a major vulnerability will result in a higher price for the coin.

In early December, I set a fairly conservative 2026 price target of $130,000 for Bitcoin (BTC +1.72%). Then, this month, I upped that target to $150,000 or higher before year-end.

The earlier figure substantially underweighted the impact of a value-generating process that I expect to accelerate significantly in 2026, because if it doesn't, Bitcoin might experience one of its very few existential risks. Here's how and why my thinking evolved.

Image source: Getty Images.

Fixing this risk is a top priority As a decentralized cryptocurrency with no issuer and no one governing body or entity with majority ownership, Bitcoin is remarkable because it's still being actively developed and advocated for by a dedicated group of individuals who work together autonomously. The coin's developer community works each day to fix issues, discuss potential improvements, and avoid making hasty changes that might compromise the value of the asset or the functionality of its blockchain.

On a technical basis, Bitcoin relies on digital signatures and cryptography to prove that only the owner of a given private key can spend the coins in the wallet that the key controls. That cryptography relies on absurdly complicated math problems that are very difficult to solve, even using powerful computers.

However, that last statement needs an asterisk at the end, as its cryptography is only unapproachably difficult to crack using the classical computers that exist today. A sufficiently powerful quantum computer could, in principle, break Bitcoin's encryption, and enable the theft of coins. And if the blockchain is proven to be under quantum attack before any mitigations are in place, the value of everyone's coins will decline very quickly.

Today's Change

(

1.72

%) $

1552.79

Current Price

$

92033.00

The important caveat is that no one has demonstrated a quantum computer capable of doing this to Bitcoin at scale today, and pretty much all serious analyses of the matter still frame the threat as a threshold event that depends on major advances in quantum computing hardware. Those advances are still at least a handful of years out, even under the most pessimistic assumptions. But quantum computing is still extremely dangerous, as it's one of the few threats that could theoretically derail Bitcoin despite its decentralization.

Having a mitigation plan in hand will be a boon From an investor's perspective, the risk posed by quantum computing thus forces the existence of a discount to the coin's valuation because it's one of the few scenarios that could plausibly undermine basic ownership of the asset. Addressing the risk by upgrading the chain would thus allow the coin's value to rise, erasing the discount. This is the basis for increasing my price target, as all of the other elements of the investment thesis that went into my past price target are also still in play.

Given the increasing urgency of the discussion across social media and the relevant technical forums, 2026 is almost certainly going to be a critical year for the Bitcoin community to hash out how a transition to a quantum-secure version of the asset will look. Importantly, I do not believe that the actual technical fixes needed will be performed this year, or even that they will be performed all at once. What I'm betting on is that the discussions about what to do are going to advance considerably, and start to form a consensus regarding what the best approach will be.

This is plausible, as quantum computer-resistant cryptographic algorithms are already known, and the U.S. government even has a set of guides regarding what security standards to use to ensure post-quantum cryptographic security. Once the developer community agrees on a handful of the related governance and implementation issues -- which, by the way, are not trivial -- it's likely that the market will price in the higher likelihood of a quantum-resistant Bitcoin down the line.

In other words, assuming that 2026 brings credible signals of consensus and even a smidgen of implementation progress, Bitcoin's price could rise because one of its nastiest risks starts looking containable instead of inexorably looming closer and provoking dread.

Of course, you probably still shouldn't take my $150,000 price target literally. A lot of macro factors will be in play this year, same as always, and they could easily rain on the parade -- or make it even better than anticipated.

Dogecoin (DOGE) has stepped into 2026 with a powerful narrative behind it, yet the price action tells a far more restrained story. 

While headlines around U.S spot Dogecoin ETFs and institutional interest continue to stack up, Dogecoin price performance has failed to mirror the excitement.

At press time, Dogecoin price is trading at $0.1401, with an intraday uptick of over 2%, replicating that bulls are trying to gain dominance.

Dogecoin Price Struggles to Clear Key Resistance AgainDogecoin’s price chart structure remains weak. For the past few sessions, Dogecoin has faced rejections multiple times from the trendline barrier of $0.1550. 

This level has now evolved into a psychological hurdle, a barrier that bulls must decisively break to revive upside momentum.

Despite an intraday price uptick of over 2%, DOGE price has been unable to sustain higher highs. This suggests that bears still hold their shape.

The current price action shows small doji and longer wicks which highlights hesitation on both sides. The momentum indicators typically align with this setup by flattening out, reinforcing the idea that neither buyers nor sellers have full control. 

As direction remains unresolved but increasingly sensitive to any strong catalyst, patience remains the key. For bulls to gain dominance, DOGE price must surpass the key hurdle of $0.1600, which may open the doors to retest the major hurdle of $0.1800-$0.1900 ahead.

DOGE Gets ETF Exposure, Still Waits for Real DemandRecent developments around Dogecoin ETFs have added fresh credibility to Dogecoin’s long-term outlook. This week, 21Shares officially announced the launch of its spot Dogecoin ETF after receiving approval from the U.S SEC to list the product on Nasdaq under the ticker TDOG.

🚨21Shares announced the launch of its spot Dogecoin ETF this week after receiving approval from the SEC to list on Nasdaq under the ticker $TDOG.

This makes it the third spot $DOGE ETF and adds more regulated access for investors. pic.twitter.com/0OOCi2irFX

— Crypto Coin Show (@CryptoCoinShow) January 13, 2026 Notably, this marks the third spot DOGE ETF to enter the regulated U.S market, expanding institutional-grade access to the memecoin.

Despite the regulatory greenlight and growing availability, capital inflows have yet to scale meaningfully. For now, the ETF story strengthens Dogecoin’s legitimacy, but sustained demand will be key for price follow-through.

Final ThoughtsDespite the price consolidation, Dogecoin’s trading activity remains steady and continues to respect the 20 day EMA support. A confirmed breakout above $0.1600 would trigger an upward momentum and may push DOGE toward $0.1800 ahead.

While a drop below the immediate support zone of $0.1320 may push DOGE to retest the recent lows of $0.1200.

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

BNB traded at $900.40 at the time of writing, down 1.32% in the last 24 hours, as its market cap climbed to about $124.02 billion. This move pushed BNB ahead of XRP, which traded at $2.04 with a market cap of $123.93 billion.

Source: CoinCodex

The flip occurred during a period of steady trading volume for both assets, with BNB posting roughly $2.1 billion in daily volume and XRP recording about $2.69 billion, a 8% drop in the last 24 hours. What drove the change in rankings this time?

Ecosystem Funding Supports DemandRecent announcements from the BNB Chain Foundation reshaped market attention. The foundation launched a $100 million liquidity program focused on direct token purchases across the ecosystem. This initiative targets projects in DeFi, gaming, artificial intelligence, and meme sectors with minimum market cap and volume thresholds. 

By committing capital directly to ecosystem tokens, the program aimed to deepen liquidity and improve market integration. Market participants tracked these purchases closely, since each allocation came with public disclosure on official channels.

Memecoin Strategy Signals Broader ShiftAlongside the liquidity program, the foundation invested $200,000 across four Chinese memecoins ahead of a major network upgrade. Each project received $50,000, and price reactions followed quickly. One of the funded tokens posted double-digit gains within 24 hours, while volumes rose across related pairs. 

This approach highlighted how cultural narratives and community-driven assets now influence activity on large networks. The timing also mattered, since the investment preceded a core protocol upgrade designed to handle higher transaction loads.

Fermi Hard Fork ApproachesThe Fermi hard fork, scheduled for January 14, stands as another factor behind BNB’s momentum. The upgrade will reduce block times from about 0.75 seconds to roughly 0.45 seconds. Faster confirmations should improve throughput and lower congestion during high-traffic periods. 

Developers expect smoother performance for applications that rely on rapid execution, including memecoin trading and gaming platforms. As the activation date nears, traders have adjusted positioning around potential changes in network usage.

On-Chain Fees Reflect Rising ActivityData from the past 24 hours showed BNB Chain ranking among the top networks by transaction fees, a position often associated with Solana or Hyperliquid. Fees often reflect real usage rather than speculation alone. When users transact more frequently, fee totals rise alongside demand for block space. 

Source: X

This trend suggested growing activity across decentralized applications and exchanges on BNB Chain. In contrast, XRP’s network metrics remained steadier, with fewer short-term shifts tied to ecosystem funding or upgrades.

Technical Levels Draw AttentionMarket technicians have also focused on BNB’s price structure. Charts showed the token approaching a key resistance zone near $930, where a descending trendline converges with prior price levels. Traders often watch such areas for confirmation of momentum. 

Source: TradingView

A sustained move above that range could influence sentiment across the broader BNB Chain ecosystem, since many tokens correlate with the network’s native asset. XRP, meanwhile, continued to trade within a narrower range during the same period.

Market Context Frames the FlipThe market cap flip between BNB and XRP reflected more than a single price move. It combined ecosystem investment, upcoming network changes, and measurable on-chain activity. As capital flowed toward networks showing higher usage and development incentives, rankings adjusted accordingly. 

Whether this ordering holds will depend on how activity evolves after the Fermi upgrade and ongoing funding efforts. For now, the data shows BNB reclaiming the fourth spot, reshaping the competitive landscape among large-cap crypto assets.

The cryptocurrency market’s performance has improved over the past few hours as Bitcoin, Ether, and other leading cryptos are in the green.

Monero’s XRM is leading the way in terms of performance as it hit a new all-time high of $688 an hour ago, adding 17% to its value in the last 24 hours.

Ether has reclaimed the $3,100 level and could rally higher in the near term as the bullish momentum in the market increases.

BitMine purchases 24k Ether to bring total holdings to 4.17 million Copy link to section

BitMine Immersion Technologies announced today that it added 24,266 Ether to its balance sheet last week, lifting its holdings to 4,167,768 tokens as of Sunday. 

The purchase pushes BitMine’s share of ether’s circulating supply to 3.45%, with a goal to ultimately corner 5% of all tokens.

However, according to BitMine’s chairman, Thomas Lee, the company’s ability to continue accumulating ETH depends on shareholder approval to authorise new equity issuance.

If the shareholders don’t approve, BitMine could be forced to slow its buying over the next few weeks. 

“We need to pursue this increase now as Bitmine is soon to exhaust its current 500 million authorisation. And when that happens, our ETH accumulation will slow,” Lee added.

A shareholder vote will take place on Thursday. 50.1% of the votes will be needed to approve the proposal to proceed. 

Following this recent acquisition, BitMine’s total assets, including crypto, cash, and strategic investments, surged to $14 billion last week, boosted by ETH’s price surpassing $3,100. 

BitMine also increased its cash reserves by $73 million to $988 million. The company holds 193 bitcoin and a $23 million stake in Eightco Holdings.

Furthermore, BitMine also staked over 1.2 million of its ETH, which allows it to earn revenue on its holdings.

ETH eyes $3,500 as crucial support level holds Copy link to section

The ETH/USD 4-hour chart remains bearish as Ether has lost 3% of its value in the last seven days.

At press time, ETH is trading at $3,133, up by less than 1% since Monday.

The technical indicators remain bullish, suggesting that buyers are still in control.

The Relative Strength Index (RSI) of 54 is above the neutral 50, indicating a bullish bias.

The MACD lines are also within the positive territory as buyers remain in charge.

If the bullish trend strengthens, ETH could surge towards the next major resistance level and Transactional Liquidity (TLQ) at $3,300.

An extended bullish scenario could see ETH reclaim $3,500 for the first time since November 13.

However, if the market undergoes a correction, ETH could retest the Thursday low of $3,038. The next major support level stands around the $2,900 region.

The privacy coins narrative is not abandoned, as more attention has shifted to legacy coins. XMR and DASH extended their rallies with a growing mindshare. 

Privacy coins are back, with attention this time shifting to Monero (XMR) as the leading coin. Legacy asset DASH also increased its influence in the past few days. 

The privacy coins narrative demonstrated its strength despite the slowdown of ZCash (ZEC), which was the original runner. Currently, XMR has taken the role of the leading privacy coin, extending its rally to new all-time highs. 

As Cryptopolitan reported earlier, XMR had a series of new records, which are now turning into an even more dramatic trend. 

XMR becomes the privacy coin leader While ZEC consolidated above $400, XMR extended its rally. The coin expanded to $679.14, marking a series of records within minutes on Tuesday. 

The recent XMR rally meant some of the early Monero supporters from the 2018 bull cycle are finally in profit with a new all-time peak. XMR lagged behind other assets and was barely touched by the series of bull markets, as the coin was delisted from most exchanges. 

XMR expanded to new all-time highs on a mix of a short squeeze and an accelerating privacy narrative. On Asian markets, XMR orders peaked at over $1,000. | Source: CoinGecko. XMR failed to live up to the expectation for a four-digit price, but the recent rally is reviving those predictions. The coin saw anomalous orders all the way up to $1,000 on the Asian markets, driving the rest of the exchanges to follow. 

Monero re-emerged despite the exchange delistings and is now serving as an alternative to ZEC as the go-to privacy coin. With stricter wallet reporting regulations, XMR is rediscovering its niche as a hard-to-trace store of value, which cannot be linked to an identity or a wallet cluster. 

XMR is now in price discovery territory, though with 44% of volumes concentrated on KuCoin. Kraken is the most open platform for trading XMR, though the coins must be deposited as non-anonymous assets. 

Open interest for derivative traders also jumped to a new all-time high, from a baseline of $30M to over $184M. Over 61% of the open positions are shorting XMR, meaning the rally is partially a short squeeze to liquidate positions.

DASH returns along with other legacy privacy coins DASH was also among the day’s top gainers, expanding to over $51. However, DASH is still far from its all-time peak of over $1,100. The privacy coin still benefits from a Binance pair, as the asset was not delisted during the removal of privacy coins. 

Decred (DCR) also expanded to $18.89 with a strong intra-day rally, though the token has not grown its influence and is only reacting to the privacy narrative. XVG moved back to a one-month high of $0.007. 

At this stage, XMR is still the main engine of growth, but smaller tokens may be picked for short-term gains. Despite the lack of an overall altcoin market, the privacy narrative is seen as a strong source of growth for the year ahead.

The smartest crypto minds already read our newsletter. Want in? Join them.

21Shares announced Tuesday the listing of its new exchange-traded product combining bitcoin and gold on the London Stock Exchange. Developed in collaboration with ByteTree Asset Management, the product is the first UK-listed ETP to combine a crypto asset and a traditional asset available to retail investors.

The ETP, trading under the ticker BOLD, uses a rules-based strategy that rebalances monthly. Its allocation between the two assets is determined by their inverse historical volatility, weighting the portfolio toward the asset that has demonstrated relative stability, 21Shares said.

According to the statement, BOLD had $40.1 million in assets under management as of Jan. 12, and a three-year Sharpe ratio of 1.79. The product is physically backed, with underlying assets held in cold storage by an institutional custodian. It carries a 0.65% annual management fee and is quoted in pound sterling, per the release.

“BOLD is an exciting new product that aims to offer investors a potential hedge against inflation, exposure to Bitcoin’s growth potential, and the relative stability of gold,” 21Shares CEO Russell Barlow said. “Now that retail investors in the UK have access to crypto ETPs, 21shares is dedicated to delivering a wider selection of innovative regulated products.”

Regulatory shift fuels UK market expansion The launch follows the FCA’s removal of a four-year retail ban on crypto exchange-traded notes in October 2025. The decision allowed retail investors to access previously professional-only products through UK-regulated platforms, including standard brokerage accounts and tax wrappers such as ISAs and SIPPs.

By December 2025, London Stock Exchange data showed over $280 million in crypto ETN trading volume in the month following the retail ban lift. The surge positioned the UK as Europe’s third-largest market for crypto ETPs by volume, with a daily average of $11.7 million traded on the exchange.

Several major asset managers expanded access concurrently with the rule change. On Oct. 20, 2025, 21Shares, Bitwise, and WisdomTree opened UK retail access to their physically-backed Bitcoin and Ethereum ETPs on the LSE. BlackRock listed its iShares Bitcoin ETP on the exchange the same week.

Meanwhile, the UK government is pursuing a phased regulatory approach for digital assets, with comprehensive rules covering stablecoins, trading, and staking under consultation as part of the FCA’s crypto roadmap.

Disclaimer: The Block is an independent media outlet that delivers news, research, and data. As of November 2023, Foresight Ventures is a majority investor of The Block. Foresight Ventures invests in other companies in the crypto space. Crypto exchange Bitget is an anchor LP for Foresight Ventures. The Block continues to operate independently to deliver objective, impactful, and timely information about the crypto industry. Here are our current financial disclosures.

© 2026 The Block. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

Fidelity Labs managing partner Parth Gargava says bitcoin may be transitioning away from its familiar, halving-linked four-year rhythm and into something closer to a “supercycle”, a regime that could keep prices elevated for longer and make drawdowns less severe, if structural demand continues to build.

Speaking in Fidelity’s Jan. 9 crypto outlook for 2026 video, Gargava anchored the discussion in the cycle framework many market participants have used for years: peaks arriving roughly a year and a half after each halving. “Traditionally, what we have seen is Bitcoin has had this four-year cycle,” he said, adding that the pattern has been “highly correlated to Bitcoin’s halving events.” He pointed to the 2016 halving followed by a peak in December 2017 near $20,000, and the 2020 halving followed by another peak in 2021 about 18 months later.

That history matters because it frames the debate around the most recent halving in April 2024. Gargava acknowledged the straightforward inference some investors make from prior cycles: “So maybe we are past that peak price.” But he positioned that view as only one side of the argument, highlighting a competing thesis that the market’s structure is evolving.

“On the other side, you’re also seeing a lot of arguments around how we might have entered into a supercycle as opposed to what we have seen in the past four years,” Gargava said. “And what a super cycle really means is you might have more prolonged highs, longer highs, and shallower dips.”

Gargava credited Fidelity Digital Assets’ research team for outlining what he called the “super cycle mechanism,” and suggested an analogy to the commodities market in the 2000s. The key point was not that bitcoin would mechanically copy commodities, but that a sustained, multi-year bid can alter how markets behave, extending expansions and compressing the depth of selloffs.

JUST IN: $5 trillion Fidelity talks about how #Bitcoin might have entered a “supercycle”

Bullish 🚀 pic.twitter.com/IUv3GVHwEW

— Bitcoin Magazine (@BitcoinMagazine) January 12, 2026

Three Forces That Could Push Bitcoin Into A Supercycle He outlined three drivers he believes could underpin that kind of regime shift.

First is “steady buy-in by institutions focused on ETFs,” which Gargava framed as persistent demand rather than episodic speculative bursts. In his telling, ETFs can function as a channel that keeps incremental capital flowing even when sentiment softens, potentially changing the market’s typical post-peak unwind.

Second is policy. Gargava pointed to “pro-crypto policies” in the US as a supportive backdrop, implying that a friendlier regulatory stance could reduce headline risk and encourage broader participation from investors and intermediaries that previously stayed on the sidelines.

Third is market maturation and changing correlations. “We’re also seeing how the crypto market as a whole is maturing and deviating from the S&P 500 and precious metals,” he said. The implication is that bitcoin’s trading behavior may be becoming less captive to traditional risk-asset moves and the simple “digital gold” narrative, an evolution that could matter for positioning, hedging, and macro sensitivity.

Notably, Gargava did not claim the four-year cycle is definitively broken. Instead, he presented a live question for 2026: whether bitcoin continues to follow a post-halving path that culminates in a familiar, sharp boom-and-bust pattern, or whether structural forces: ETF-driven institutional demand, a more supportive US policy tone, and a maturing market profile support a longer, steadier expansion with “shallower dips.”

At press time, Bitcoin traded at $92,182.

Bitcoin needs to overcome the 0.618 Fib, 1-week chart | Source: BTCUSDT on TradingView.com Featured image created with DALL.E, chart from TradingView.com

Tue, 13/01/2026 - 11:03

XRP is breaking payments volume record from 2025, suggesting an upcoming market boom.

Cover image via U.Today Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

There is more going on with XRP than just price noise at the moment. The XRP Ledger's on-chain activity recently recorded its highest payment count in about 180 days, with daily transactions reaching about 1.45 million. That is a structural indication that usage is resuming after a protracted cooling-off period, not a chance spike. XRPs on-chain metrics have a history of cyclical movement.

Payment count explosionWeekends and holidays cause activity to drastically slow down, but once regular settlement flows resume, it picks back up quickly. What counts in this case is that the rebound exceeded recent local highs rather than simply returning to baseline. This implies that involvement is growing rather than being a one-time outburst from a single actor. 

Source: XRP ScanLook at the price chart next to that now. Sitting below the 200 EMA and having difficulty regaining higher moving averages, XRP is still trading below significant long-term resistance zones. This is not yet a confirmed bull trend from a technical standpoint. After emerging from a protracted downtrend channel, the asset recently recovered from local lows and is currently consolidating around short-term EMAs.

HOT Stories

XRP pushes throughThis is typical reset behavior: the market determines whether there is sufficient demand to push higher volatility contracts and momentum indicators stabilize. Divergence is crucial. While the price is still relatively low, on-chain activity is increasing. This typically indicates one of two things: either the price eventually needs to rise to keep up with the rise in usage or the network activity fades once more and the price goes down. 

You Might Also Like

Sustained growth in the number of payments tends to precede rather than follow directional moves, as XRP has repeatedly demonstrated. Investors should not anticipate a breakout right away. Reclaiming the 50 and 100 EMAs would be a powerful first signal, but the chart still needs confirmation. 

However, the current arrangement prioritizes patience over fear. In contrast to purely speculative pumps rising, transaction counts show that XRP is being used actively rather than just traded, which lowers downside risk.

To put it succinctly, XRP looks early rather than late. Longer-term opportunities typically arise when on-chain data is leading and price is lagging.

Related articles

Ripple Urges SEC to Move Beyond “Decentralization” in Crypto RegulationOn January 9, 2026, Ripple submitted a formal letter to the SEC Crypto Task Force advocating for a fundamental shift in how digital assets are regulated. 

Well, the company is pushing regulators to move beyond the increasingly criticized “decentralization” test and instead focus on enforceable rights and obligations to determine whether a crypto asset should fall under securities law.

Ripple argues that “decentralization” is an inherently subjective and fluid concept, influenced by factors such as code contributions, node distribution, economic incentives, and governance participation. Because decentralization exists on a continuum rather than as a binary state, relying on it as a legal metric creates uncertainty, legal risk, and inconsistent outcomes. 

According to Ripple, this approach can lead to both “false negatives,” where assets that should be regulated avoid oversight by appearing diffuse, and “false positives,” where market-proven assets remain trapped in securities regulations due to ongoing participation by developers or holders.

Why does this matter? Well, Ripple’s letter urges regulators to separate the security offering from the asset itself. Once the original contractual obligations end, secondary market trades should no longer be treated as securities. 

Ripple acknowledges that privity, the legal link between issuer and initial investor, matters only in primary sales, not in mature markets. This approach mirrors SEC Chair Mark Atkins’ view that obligations tied to an offering naturally expire over time.

Therefore, Ripple’s submission urges clear, practical crypto regulations, championing a rights-based framework that separates assets from their original offerings. 

By pushing for legal certainty, Ripple is shaping a path for responsible innovation and broader institutional adoption, guiding the SEC toward rules that reflect the realities of digital assets in 2026 and beyond.

ConclusionRipple is calling for a shift from subjective decentralization tests to a clear, rights-based regulatory framework, setting a precedent for the entire crypto industry. 

By emphasizing enforceable obligations, privity, and the natural expiration of contractual promises, Ripple advocates for rules that deliver certainty, protect investors, and let digital assets thrive without regulatory overreach. 

Notably, Ripple’s approach provides a practical blueprint for distinguishing between assets and offerings, paving the way for a transparent, efficient, and innovation-friendly market.

The Google logo is seen on the Google house at CES 2024, an annual consumer electronics trade show, in Las Vegas, Nevada, U.S. January 10, 2024. REUTERS/Steve Marcus Purchase Licensing Rights, opens new tab

Jan 13 (Reuters) - Google (GOOGL.O), opens new tab will start developing and manufacturing high-end smartphones in Vietnam this year, Nikkei Asia reported on Tuesday, citing sources familiar with the matter.

Reuters could not immediately verify the report.

Sign up here.

Google will begin new product introductions (NPI) for its Pixel, Pixel Pro and Pixel Fold phones in Vietnam, with development of the lower-end Pixel A series remaining in China for now, the report added.

Reporting by Ananya Palyekar in Bengaluru; Editing by Rashmi Aich

Our Standards: The Thomson Reuters Trust Principles., opens new tab

The chipmaker is one of the biggest success stories of the last decade.

It's no secret that Nvidia (NVDA +0.04%) has been an incredible investment, especially during the artificial intelligence (AI) boom. The chipmaker's graphics processing units (GPUs) are in high demand from tech companies building out their data centers.

Even with that in mind, the amount of money an early investor could've made in Nvidia is still hard to believe.

Image source: Nvidia.

How much a $1,000 Nvidia investment would've grown If you'd invested $1,000 in Nvidia stock 10 years ago and held on to your shares until today, you'd be sitting on $255,740 (as of Jan. 10). That's over a quarter of a million from one winning stock. An identical investment in the S&P 500 would be worth $4,309.

There are several valuable lessons to be learned from Nvidia's success. You can get life-changing results from investing in winning stocks, and it's definitely possible to find them as a retail investor. The Motley Fool first recommended Nvidia over 20 years ago, in April 2005.

Today's Change

(

0.04

%) $

0.08

Current Price

$

184.94

It's not just about finding winning stocks, though. You also need to stick with them through the highs and the lows, provided you still believe they're quality companies. Let's revisit the hypothetical of investing $1,000 in Nvidia 10 years ago. After five years, your investment would've been worth $18,320. You might have been tempted to take your profits, and that would mean missing out on the $237,420 in returns Nvidia delivered over the next five years.

Nvidia almost certainly won't be delivering those kinds of results anymore, but it remains a sound investment due to its role as one of the leading AI companies. The chipmaker serves as a solid foundational stock in a portfolio. You may also want to invest in some smaller stocks that you think have the potential to be the next Nvidia.

Lyle Daly has positions in Nvidia. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy.

Here are three stocks with buy rank and strong value characteristics for investors to consider today, Jan. 13:

American Public Education, Inc. (APEI - Free Report) : This education services provider carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.9% over the last 60 days.  

American Public Education has a price-to-earnings ratio (P/E) of 18.16, compared with 25.57 for the S&P. The company possesses a Value Score  of B.

KNOT Offshore Partners LP (KNOP - Free Report) : This tanker shipping company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its next year earnings increasing 41.3% over the last 60 days.

KNOT Offshore Partners LP has a price-to-earnings ratio (P/E) of 7.66, compared with 25.57 for the S&P. The company possesses a Value Score of A.

CF Industries Holdings, Inc. (CF - Free Report) : This industrial gases company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.6% over the last 60 days

CF Industries has a price-to-earnings ratio (P/E) of 11.36, compared with 12.40 for the industry. The company possesses a Value Score of A.

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

Walmart (WMT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.